HSP90AB1 and glioma: NXD30001 could easily crosses the BBB and accumulates in the brain and would not cause liver or ocular toxicity in vivo, made it be an attractive therapeutic candidate for gliomas by downregulating Hsp90 client oncoproteins to inhibit tumor cell proliferation and induce cell apoptosis.